Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN
度伐利尤单抗联合或不联合曲美利尤单抗，加铂类-依托泊苷一线治疗广泛期小细胞肺癌：CASPIAN研究3年总生存期更新
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100408
Paz-Ares, L; Chen, Y; Reinmuth, N; Hotta, K; Trukhin, D; Statsenko, G; Hochmair, M J; Özgüroğlu, M; Ji, J H; Garassino, M C; Voitko, O; Poltoratskiy, A; Musso, E; Havel, L; Bondarenko, I; Losonczy, G; Conev, N; Mann, H; Dalvi, T B; Jiang, H; Goldman, J W
